Barry Berman, MD, MS
Board-certified in medical oncology, hematology, and internal medicine, Dr. Berman earned his medical degree from the University of South Florida College of Medicine, received his internal medicine training at the University of South Florida, and completed his fellowship in medical oncology and hematology at the University of South Florida, H. Lee Moffitt Cancer Center.
Serving many years as a board member for the Florida Society of Clinical Oncology (FLASCO), Dr. Berman also held positions as Clinical Practice Committee Chair, Vice President, Secretary and Treasurer for FLASCO. He currently chairs the finance committee for FLASCO. He has also served on the American Society of Clinical Oncology (ASCO) Practice Guideline Implementation Network (PGIN) Committee since 2015 and was an author on three of the current guidelines. He also served as chair of the Investigational Review Board at Broward Health.
As a cancer researcher, Dr. Berman has been actively engaged in multiple clinical studies over the last 29 years and has been published in many peer-reviewed journals.
In his spare time, Dr. Berman enjoys photography, traveling, spending time with his family, and teaching his miniature Australian Shepard new tricks.
- Hematology
- Medical Oncology
- English
Medical School
University of South Florida – Tampa, FL
Residency
University of South Florida – Tampa, FL
Fellowship
Medical Oncology/Hematology – University of South Florida/H. Lee Moffitt Cancer Center – Tampa, FL
Board Certification
Medical Oncology
Hematology
Internal Medicine
Honors & Achievements
Palm Beach Illustrated Top Doctor – Hematology and Oncology – 2024
Professional Affiliations
American Society of Clinical Oncology (ASCO)
ASCO Practice Guideline Implementation Network (PGIN), Committee Member
Florida Society of Clinical Oncology (FLASCO), Secretary
American Medical Association
American Society of Internal Medicine
American College of Physicians
Southern Association of Oncology
In the United States, Colon cancer affects 1 in 23 men – nearly 5% of all men are at risk of developing this disease in their lifetime. The availability of effective early screening and the ease of making lifestyle changes improve the outlook. In recognition of Men’s Health Month, Florida Cancer Specialists medical oncologist Dr. Barry Berman joins the conversation to help raise awareness and understanding of this disease.
One in eight American males will be diagnosed with prostate cancer in their lifetime, so it’s important to know the facts. Florida Cancer Specialists medical oncologists Dr. Barry Berman and Dr. Mahdi Taha discuss who is most at risk and the recommended screenings, as well as the individualized treatments available. FCS offers clinical trials as an added option for achieving the best possible outcomes.